284 related articles for article (PubMed ID: 33670740)
1. Unique Benefits of Tumor-Specific Nanobodies for Fluorescence Guided Surgery.
Lwin TM; Hoffman RM; Bouvet M
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670740
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.
Lwin TM; Hernot S; Hollandsworth H; Amirfakhri S; Filemoni F; Debie P; Hoffman RM; Bouvet M
Surgery; 2020 Jul; 168(1):85-91. PubMed ID: 32370916
[TBL] [Abstract][Full Text] [Related]
3. Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
Lwin TM; Turner MA; Amirfakhri S; Nishino H; Debie P; Cosman BC; Hoffman RM; Hernot S; Bouvet M
J Surg Oncol; 2021 Dec; 124(7):1121-1127. PubMed ID: 34309885
[TBL] [Abstract][Full Text] [Related]
4. Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery.
Debie P; Van Quathem J; Hansen I; Bala G; Massa S; Devoogdt N; Xavier C; Hernot S
Mol Pharm; 2017 Apr; 14(4):1145-1153. PubMed ID: 28245129
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection.
Bannas P; Lenz A; Kunick V; Well L; Fumey W; Rissiek B; Haag F; Schmid J; Schütze K; Eichhoff A; Trepel M; Adam G; Ittrich H; Koch-Nolte F
Contrast Media Mol Imaging; 2015; 10(5):367-78. PubMed ID: 25925493
[TBL] [Abstract][Full Text] [Related]
6. Applications of Nanobodies.
Muyldermans S
Annu Rev Anim Biosci; 2021 Feb; 9():401-421. PubMed ID: 33233943
[TBL] [Abstract][Full Text] [Related]
7. Nanobodies and their potential applications.
Hassanzadeh-Ghassabeh G; Devoogdt N; De Pauw P; Vincke C; Muyldermans S
Nanomedicine (Lond); 2013 Jun; 8(6):1013-26. PubMed ID: 23730699
[TBL] [Abstract][Full Text] [Related]
8. Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics.
Al-Baradie RS
Hum Antibodies; 2020; 28(4):259-272. PubMed ID: 32831197
[TBL] [Abstract][Full Text] [Related]
9. In vivo near-infrared fluorescence targeting of T cells: comparison of nanobodies and conventional monoclonal antibodies.
Bannas P; Well L; Lenz A; Rissiek B; Haag F; Schmid J; Hochgräfe K; Trepel M; Adam G; Ittrich H; Koch-Nolte F
Contrast Media Mol Imaging; 2014; 9(2):135-42. PubMed ID: 24523058
[TBL] [Abstract][Full Text] [Related]
10. INDI-integrated nanobody database for immunoinformatics.
Deszyński P; Młokosiewicz J; Volanakis A; Jaszczyszyn I; Castellana N; Bonissone S; Ganesan R; Krawczyk K
Nucleic Acids Res; 2022 Jan; 50(D1):D1273-D1281. PubMed ID: 34747487
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer.
Lwin TM; Turner MA; Nishino H; Amirfakhri S; Hernot S; Hoffman RM; Bouvet M
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625638
[TBL] [Abstract][Full Text] [Related]
12. Nanobodies and Cancer: Current Status and New Perspectives.
Allegra A; Innao V; Gerace D; Vaddinelli D; Allegra AG; Musolino C
Cancer Invest; 2018 Apr; 36(4):221-237. PubMed ID: 29658806
[TBL] [Abstract][Full Text] [Related]
13. Site-Specific Fluorescent Labeling, Single-Step Immunocytochemistry, and Delivery of Nanobodies into Living Cells.
Gettemans J
Methods Mol Biol; 2022; 2446():373-393. PubMed ID: 35157284
[TBL] [Abstract][Full Text] [Related]
14. Nanobody click chemistry for convenient site-specific fluorescent labelling, single step immunocytochemistry and delivery into living cells by photoporation and live cell imaging.
Hebbrecht T; Liu J; Zwaenepoel O; Boddin G; Van Leene C; Decoene K; Madder A; Braeckmans K; Gettemans J
N Biotechnol; 2020 Nov; 59():33-43. PubMed ID: 32659511
[TBL] [Abstract][Full Text] [Related]
15. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
16. Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.
Deken MM; Kijanka MM; Beltrán Hernández I; Slooter MD; de Bruijn HS; van Diest PJ; van Bergen En Henegouwen PMP; Lowik CWGM; Robinson DJ; Vahrmeijer AL; Oliveira S
J Control Release; 2020 Jul; 323():269-281. PubMed ID: 32330574
[TBL] [Abstract][Full Text] [Related]
17. General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold.
Vincke C; Loris R; Saerens D; Martinez-Rodriguez S; Muyldermans S; Conrath K
J Biol Chem; 2009 Jan; 284(5):3273-3284. PubMed ID: 19010777
[TBL] [Abstract][Full Text] [Related]
18. Emerging applications of nanobodies in cancer therapy.
Awad RM; Meeus F; Ceuppens H; Ertveldt T; Hanssens H; Lecocq Q; Mateusiak L; Zeven K; Valenta H; De Groof TWM; De Vlaeminck Y; Krasniqi A; De Veirman K; Goyvaerts C; D'Huyvetter M; Hernot S; Devoogdt N; Breckpot K
Int Rev Cell Mol Biol; 2022; 369():143-199. PubMed ID: 35777863
[TBL] [Abstract][Full Text] [Related]
19. Engineering nanobodies for next-generation molecular imaging.
Yang E; Liu Q; Huang G; Liu J; Wei W
Drug Discov Today; 2022 Jun; 27(6):1622-1638. PubMed ID: 35331925
[TBL] [Abstract][Full Text] [Related]
20. Nanobodies Enhancing Cancer Visualization, Diagnosis and Therapeutics.
Naidoo DB; Chuturgoon AA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]